Trials that use: Multiple imputation / missing data
New to this method? Read the tutorial →
9,924 results
- First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration: Complete Statistical AnalysisIndependent statistical analysis of First-in-Human Study of LHA510 in Elderly Subjects and Patients With Age-Related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Complete Statistical AnalysisIndependent statistical analysis of First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High…
- First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19.: primary endpoint results, effect estimate with…
- First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221: Complete Statistical AnalysisIndependent statistical analysis of First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01524991).
- First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC: Complete Statistical AnalysisIndependent statistical analysis of First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy Participants: Complete Statistical AnalysisIndependent statistical analysis of First-Time-in-Human (FTIH) Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of VH4004280 in Healthy Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FirstStep2Health Intervention: Complete Statistical AnalysisIndependent statistical analysis of FirstStep2Health Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04164277).
- FISATABIIndependent statistical analysis of Feasibility of Improving Sleep Apnea Treatment Adherence After Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04221009).
- Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil and Nonalcoholic Fatty Liver Disease (NAFLD) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01285362).
- Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- FITESTIndependent statistical analysis of Financial Incentives Telephone Education and Skills Trial in African Americans With Diabetes (FITEST): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- FITSTART+Independent statistical analysis of Parent Feedback Intervention Targeting Student Transitions and Alcohol Related Trajectories (+) Efficacy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension: Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Combination of Bisoprolol and Amlodipine in the Treatment of Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): Complete Statistical AnalysisIndependent statistical analysis of Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): Complete Statistical AnalysisIndependent statistical analysis of Fixed-dose Safety and Efficacy Study of Asenapine for the Treatment of Acute Manic or Mixed Episode in Bipolar 1 Disorder (P05691): primary endpoint results, effect estimate with confidence…
- FLAMEIndependent statistical analysis of the FLAME phase 3 trial of QVA149 versus LABA/ICS in COPD, including exacerbation rates, time-to-event analyses, non-inferiority methodology, safety, and statistical interpretation.
- FLAMEIndependent statistical analysis of Flexibility, Alcohol Misuse, and Excitation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06634771).
- FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides): Complete Statistical AnalysisIndependent statistical analysis of FLASH [Fluorescent Light Activated Synthetic Hypericin] Clinical Study: Topical SGX301 (Synthetic Hypericin) for the Treatment of Cutaneous T-Cell Lymphoma (Mycosis Fungoides): primary endpoint results, effect estimate with confidence…
- Flatbush FHC Proactive Colorectal Cancer Screening and Navigation: Complete Statistical AnalysisIndependent statistical analysis of Flatbush FHC Proactive Colorectal Cancer Screening and Navigation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05646355).
- FLAXPADIndependent statistical analysis of Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- FLEXIndependent statistical analysis of Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Flex HDIndependent statistical analysis of Feasibility Study of The Use of FLEX HD® Surgical Implant or STRATTICE® Reconstructive Tissue Matrix in The Closure of Abdominal Wall Defects With Component Separation in Clean or…
- FLEX MIndependent statistical analysis of A Rheumatoid Arthritis Study in Participants on a Background Treatment of Methotrexate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- FLEX VIndependent statistical analysis of A Study in Participants With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01202773).
- Flex-UpIndependent statistical analysis of A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis: primary endpoint results, effect estimate with confidence…
- Florbetapir Calibration to the Centiloid Scale: Complete Statistical AnalysisIndependent statistical analysis of Florbetapir Calibration to the Centiloid Scale: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02120664).
- FLOREYIndependent statistical analysis of Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FLOWIndependent statistical analysis of A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease: primary endpoint results, effect estimate with confidence…
- FLUBUTBIIndependent statistical analysis of Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01366612).
- Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight: Complete Statistical AnalysisIndependent statistical analysis of Fluconazole Prophylaxis for the Prevention of Candidiasis in Infants Less Than 750 Grams Birthweight: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL): Complete Statistical AnalysisIndependent statistical analysis of Fludarabine, Rituximab, and Lenalidomide in Minimally Treated/Untreated Patients With Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma: Complete Statistical AnalysisIndependent statistical analysis of Fludeoxyglucose F 18 Positron Emission Tomography and Magnetic Resonance Perfusion Imaging in Patients With Neurofibromatosis 1 and Plexiform Neurofibroma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Fluid Balance in the ICU – Interventions to Minimize Fluids in Patients With Septic Shock: Complete Statistical AnalysisIndependent statistical analysis of Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Fluid Chloride and AKI in Cardiopulmonary Bypass: Complete Statistical AnalysisIndependent statistical analysis of Fluid Chloride and AKI in Cardiopulmonary Bypass: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02668952).
- Flumazenil for the Treatment of Primary Hypersomnia: Complete Statistical AnalysisIndependent statistical analysis of Flumazenil for the Treatment of Primary Hypersomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01183312).
- Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00695318).
- FLUORESCEIndependent statistical analysis of Fluoxetine for Visual Recovery After Ischemic Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02737930).
- Fluorescent Evaluation of Colorectal Anastamoses: Complete Statistical AnalysisIndependent statistical analysis of Fluorescent Evaluation of Colorectal Anastamoses: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01424293).
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases: Complete Statistical AnalysisIndependent statistical analysis of Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases: primary endpoint results, effect estimate with confidence…
- Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters: Complete Statistical AnalysisIndependent statistical analysis of Fluoroscopy-guided Versus Traditional Placement of Epidural Catheters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02678039).
- Fluticasone Nasal Spray Patient Preference Study: Complete Statistical AnalysisIndependent statistical analysis of Fluticasone Nasal Spray Patient Preference Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00398476).
- FMBI With War-affected Families: Complete Statistical AnalysisIndependent statistical analysis of FMBI With War-affected Families: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05241314).
- FMT for FIIndependent statistical analysis of Fecal Microbial Transplantation for the Treatment of Fecal Incontinence in Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- FMT ObesityIndependent statistical analysis of Fecal Microbiota Transplantation for the Treatment of Obesity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02741518).
- Focal Prostate Radio-Frequency Ablation: Complete Statistical AnalysisIndependent statistical analysis of Focal Prostate Radio-Frequency Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02328807).
- Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): Complete Statistical AnalysisIndependent statistical analysis of Focal Segmental Glomerulosclerosis Clinical Trial (FSGS-CT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00135811).
- FOCUSIndependent statistical analysis of A Study of Carfilzomib vs Best Supportive Care in Subjects With Relapsed and Refractory Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- FOCUSIndependent statistical analysis of An Efficacy and Safety Study of Fremanezumab in Adults With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…